| # | Drug | Count |
|---|---|---|
| 0 | RITUXIMAB | 165 |
| 1 | PREDNISONE | 111 |
| 2 | ACETAMINOPHEN | 93 |
| 3 | NIRMATRELVIR AND RITONAVIR | 84 |
| 4 | HUMAN IMMUNOGLOBULIN G | 83 |
| 5 | ERGOCALCIFEROL | 74 |
| 6 | METHOTREXATE SODIUM | 74 |
| 7 | ACETAMINOPHEN 500MG | 64 |
| 8 | ACETAMINOPHEN TABLET EXTENDED RELEASE | 64 |
| 9 | PAIN RELIEVER | 64 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | HUMAN IMMUNOGLOBULIN G | 83 | 0.0040 |
| 1 | BARICITINIB | 12 | 0.0039 |
| 2 | INFLIXIMAB-DYYB | 13 | 0.0038 |
| 3 | BENDAMUSTINE HYDROCHLORIDE | 28 | 0.0033 |
| 4 | OBINUTUZUMAB | 53 | 0.0031 |
| 5 | ERGOCALCIFEROL | 74 | 0.0025 |
| 6 | AMOXICILLIN AND CLAVULANATE POTASSIUM | 10 | 0.0022 |
| 7 | CALCIUM, MAGNESIUM, POTASSIUM, AND SODIUM OXYBATES | 20 | 0.0022 |
| 8 | REMDESIVIR | 28 | 0.0021 |
| 9 | NIRMATRELVIR AND RITONAVIR | 84 | 0.0016 |
| # | Drug class | Count |
|---|---|---|
| 0 | CD20-directed Cytolytic Antibody [EPC] | 254 |
| 1 | Corticosteroid [EPC] | 238 |
| 2 | Nonsteroidal Anti-inflammatory Drug [EPC] | 147 |
| 3 | Human Immunoglobulin G [EPC] | 88 |
| 4 | Tumor Necrosis Factor Blocker [EPC] | 76 |
| 5 | Alkylating Drug [EPC] | 74 |
| 6 | Provitamin D2 Compound [EPC] | 74 |
| 7 | Folate Analog Metabolic Inhibitor [EPC] | 63 |
| 8 | Benzodiazepine [EPC] | 60 |
| 9 | Vitamin C [EPC] | 55 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 9 | 0.0131 |
| 1 | Human Immunoglobulin G [EPC] | 88 | 0.0042 |
| 2 | Vitamin B6 Analog [EPC] | 1 | 0.0028 |
| 3 | Provitamin D2 Compound [EPC] | 74 | 0.0025 |
| 4 | Interleukin-36 Receptor Antagonist [EPC] | 1 | 0.0025 |
| 5 | Guanylate Cyclase-C Agonist [EPC] | 5 | 0.0024 |
| 6 | SARS-CoV-2 Nucleotide Analog RNA Polymerase Inhibitor [EPC] | 28 | 0.0021 |
| 7 | Enzyme Stabilizer [EPC] | 2 | 0.0017 |
| 8 | Thymic Stromal Lymphopoietin Blocker [EPC] | 10 | 0.0014 |
| 9 | Human alpha-1 Proteinase Inhibitor [EPC] | 5 | 0.0012 |